Skip to content

Clinical trials

Phase 3 Hepatitis C trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: South Korea Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20101
20114
20124
20132
20142
20151
20161
20173
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb9
AbbVie4
GlaxoSmithKline3
Boehringer Ingelheim2
Debiopharm International SA2
Atea Pharmaceuticals, Inc.1
Bukwang Pharmaceutical1
Gilead Sciences1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C24
Hepatitis C, Chronic10
Acquired Immunodeficiency Syndrome3
Coinfection2
Fibrosis1
HIV Infections1
Hepatitis1
Hepatitis B1
Liver Diseases1
Non-alcoholic Fatty Liver Disease1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.